A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Multiple Sclerosis

In brief

The main purpose of this study is to investigate Lu AG06466 as a treatment for spasticity in participants with multiple sclerosis (MS).

Key facts

Study ID

NCT04990219

Run by

H. Lundbeck A/S

People needed

37

Starts

2021-09-27

Expected to finish

2023-01-31

Last updated by the study team

2023-02-03

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mountain View Clinical Research — Denver, Colorado, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Wake Research - Clinical Research Center of Nevada — Las Vegas, Nevada, United States
• Universitätsklinikum Düsseldorf — Dusseldorf NRW, Germany
• Neurostimulation Center for Movement Disorders — Mainz, Germany
• Center of Neurology, Hertie Institute for Clinical Brain Research — Tübingen, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.